Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03235297 · ClinicalTrials.gov registry record
Effects of Altitude on Single-Breath Diffusing Capacity for Carbon Monoxide
A clinical trial, sponsored by Intermountain Health Care.
- Completed
- Registry status
- 23
- Enrollment target
NCT03235297 is a clinical trial that has completed, run by Intermountain Health Care. The registered enrollment target is 23 participants.
The verdict
NCT03235297 has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to further understand the effects of altitude on the physiology of gas exchange in the pulmonary microcirculation in normal subjects and in people with chronic obstructive pulmonary disease (COPD) measured as the single-breath diffusing capacity for carbon monoxide (DLCOsb). The study will determine a mathematical formula to allow for altitude corrections in both study populations to be used clinically in pulmonary labs.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2017-08-10 |
| Est. Completion | 2019-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03235297
The ClinicalTrials.gov registry entry for NCT03235297 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Intermountain Health Care, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03235297 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03235297 about?
NCT03235297 is a clinical study titled "Effects of Altitude on Single-Breath Diffusing Capacity for Carbon Monoxide". The purpose of this study is to further understand the effects of altitude on the physiology of gas exchange in the pulmonary microcirculation in normal subjects and in people with chronic obstructive pulmonary disease (COPD) measured as the single-breath diffusing capacity for carbon monoxide (DLCO...
What is the current status of trial NCT03235297?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2017-08-10. Estimated completion is 2019-07-01.
Who is sponsoring clinical trial NCT03235297?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.